KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.043 14 days ( 17.30 % )
Last Price $53.91 0.335 %
High/ Low $52.81 - $54.94 1.25%
Chg 7 Days -2.07 % $55.05 $53.91
Chg 30 Days -23.16 % $70.16 $53.91
Chg 12 mos 9.77 % $49.11 $53.91
Trend - 3 mos -19.59 % Width: 43.17 %
Trend - 12 mos 22.00 % Width: 95.83 %
Pred. range - 3 mos $42.96 - $61.50 -20.31 % - 14.09 %
Pred. range - 12 mos $57.25 - $112.11 6.19 % - 107.95 %
Short MA avg 3 mos Buy Apr 08, 2024 - 15 days
Long MA avg 3 mos Sell Mar 12, 2024 - 33 days
Short/Long MA avg 3 mos Sell Mar 15, 2024 - 30 days
Short MA avg 12 mos Sell Mar 06, 2024 - 37 days
Long MA avg 12 mos Sell Mar 27, 2024 - 22 days
Short/Long MA avg 12 mos Sell Apr 10, 2024 - 13 days
Pivot Short Sell Apr 25, 2024 - 2 days
Bollinger Buy Mar 14, 2024 - 31 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT